Medicare Advantage (MA) plans and prescription drug plans (PDPs) face increasing complexity in reaching – and keeping – Star Rating targets due to changing CMS regulations and requirements. Each year, CMS introduces new metrics, raises the bar for many of the existing Star Rating measures, and discontinues others. To succeed, plans must remain poised to adapt to these changing standards.
As this quality-driven paradigm becomes even more challenging, do you have the people, processes, and technology necessary to succeed? Can you sustain a 4.0 or higher Star Rating?
In this white paper, we examine opportunities for plans to accomplish greater success with Stars and describe some tailored interventions we have seen succeed. We also outline an approach to building a quality competency to support a cycle of continued success. Our goal is to help you more confidently participate in this quality-driven market.
Your browser does not support iframes.